Nivolumab in Non-Small Cell Lung Cancer: Real World Long-Term Survival Results and Blood-Based Efficacy Biomarkers

OBJECTIVES: We aimed to examine clinical data and baseline blood test results as potential predictive biomarkers for benefit from nivolumab, in advanced non-small cell lung cancer patients (NSCLC). MATERIALS AND METHODS: A chart review was performed of 108 advanced NSCLC patients who commenced treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Daher, Sameh, Lawrence, Yaacov R., Dudnik, Elizabeth, Hanovich, Ekaterina, Urban, Damien, Peled, Nir, Navon, Rossie, Leibowitz, Raya, Hammerman, Ariel, Battat, Erez, Gottfried, Teodor, Onn, Amir, Bar, Jair
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335163/
https://www.ncbi.nlm.nih.gov/pubmed/34367942
http://dx.doi.org/10.3389/fonc.2021.625668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335163/
https://www.ncbi.nlm.nih.gov/pubmed/34367942
http://dx.doi.org/10.3389/fonc.2021.625668

Ejemplares similares